Health Care & Life Sciences » Pharmaceuticals | PharmaRoth Labs Inc.

PharmaRoth Labs Inc.

PharmaRoth Labs Inc.
Stock Exchange Other OTC
EPS
$0
Market Cap
$403.86 K
Shares Outstanding
351.18 M
Public Float
100 M

Profile

Address
10080 West Alta Drive
Las Vegas Nevada 89145
United States
Employees -
Website http://www.pharmaroth.com
Updated 07/08/2019
PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. It holds the intellectual property rights related to the production, marketing and distribution of Sucanon, a oral treatment for type II diabetes. The company was founded on December 11, 2000 and is headquartered in Las Vegas, NV.

Financials

View All
Created with Highcharts 5.0.14PharmaRoth Labs Inc.Net Income. Fiscal year is July-June. All values USD Thousands.4254252912913693692322329191201320142015201620170100200300400500
Created with Highcharts 5.0.14PharmaRoth Labs Inc.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.1531535295298787263263181181201320142015201620170100200300400500600

Luis Manuel Ornelas Lopez
Chairman, President, Chief Executive Officer & COO
Luis Manuel Ornelas Lopez
Chairman, President, Chief Executive Officer & COO